谷歌浏览器插件
订阅小程序
在清言上使用

Switching Rate from Intravenous to Subcutaneous Vedolizumab in Managing Inflammatory Bowel Diseases is Lower Than Expected

MINERVA GASTROENTEROLOGY(2024)

引用 0|浏览0
暂无评分
关键词
Crohn disease,Ulcerative colitis,Vedolizumab,Remission induction,Subcutaneous infusions,Safety.
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要